TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02395237

COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

The sponsor gave no reason.

Life of this trial

2015201620172018201920202021Registered2015-03-17Planned start2015-05 (planned)Withdrawn (as of)2020-09-18

Vital statistics

Status
Withdrawn
Phase
Phase 1
Sponsor
Pharmaceutical Research Unit, Jordan
Sponsor type
University, hospital or other
Conditions
Healthy
Interventions
: Amaryl® M IR 2/1000
Participants
0
Sites
1
Countries
Jordan

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.